Emetant-IV Injection
Marketer
Adley Formulations
Salt Composition
Fosaprepitant (150mg)
Overview Emetant-IV Injection
Oncaspar (IV) is a prescription medication preventing chemotherapy-induced nausea and vomiting. Administered by a healthcare professional, it should be taken consistently as directed; abrupt cessation requires prior physician consultation. Missed doses should be taken promptly upon recall, completing the prescribed regimen regardless of symptom improvement. Regular liver function tests may be recommended by your doctor. Potential side effects include fatigue, headache, anorexia, constipation, and hiccups. Drowsiness and dizziness are also possible; avoid driving or mentally demanding tasks until the medication's effects are understood.
Uses of Emetant-IV Injection
Chemotherapy-induced emesis
Major Benefits of Emetant-IV Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Emetant-IV Injection:
- Headache
- Hiccup
- Indigestion
- Fatigue
- Decreased appetite
- Constipation
How to use Emetant-IV Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Emetant-IV Injection works:
Emetant-IV Injection is an anti-vomiting drug that counteracts nausea and vomiting associated with chemotherapy. Its mechanism involves inhibiting a brain neurotransmitter (neurokinin) responsible for triggering these side effects.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Emetant-IV Injection and alcohol is contraindicated.
PregnancySAFE IF PRESCRIBED
The administration of Emetant-IV Injection during pregnancy is typically deemed safe. Preclinical trials using animal models have revealed minimal or no negative consequences for fetal development; nonetheless, data from human trials are scarce.
Breast feedingCONSULT YOUR DOCTOR
Administration of Emetant-IV Injection while breastfeeding is likely inadvisable. Available human data indicate potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administering Emetant-IV Injection could lead to reduced awareness, visual impairment, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneySAFE IF PRESCRIBED
Emetant-IV Injection poses no safety concerns for patients with renal impairment; no dosage alteration is necessary.
LiverCAUTION
Careful administration of Emetant-IV Injection is advised for individuals with significant hepatic impairment; dosage modification might be necessary. Physician consultation is recommended. Dosage alterations are not typically advised for patients exhibiting moderate to severe hepatic dysfunction.
What if you forget to take Emetant-IV Injection :
Should you forget a dose of Emetant-IV Injection, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Emetant-IV Injection
| Label | Value |
|---|---|
| Type of Compound | Morphinan analog |
| Potential for Dependence | None. |
| Treatment Category | Gastrointestinal tract |
| Mechanism of Action | Substance P receptor blockers |
3,018 People bought this recently